logo

PRME

Prime Medicine·NASDAQ
--
--(--)
--
--(--)

PRME fundamentals

Prime Medicine (PRME) released its earnings on Nov 7, 2025: revenue was 1.23M (YoY +499.02%), missed estimates; EPS was -0.32 (YoY +27.27%), missed estimates.
Revenue / YoY
1.23M
+499.02%
EPS / YoY
-0.32
+27.27%
Report date
Nov 7, 2025
EPS
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Q3,2025
Actual
-0.56-0.44-0.47-0.55-0.72-0.44-0.46-0.44-0.31-0.4-0.41-0.32
Forecast
-1.59-0.4144-0.4233-0.4342-0.556-0.4549-0.3898-0.3853-0.3826-0.3135-0.3512-0.2529
Surprise
+64.78%
-6.18%
-11.03%
-26.67%
-29.50%
+3.28%
-18.01%
-14.20%
+18.98%
-27.59%
-16.74%
-26.53%
Revenue
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Q3,2025
Actual
00000591.00K0204.50K2.19M1.45M1.11M1.23M
Forecast
0001.67M5.71M1.92M1.63M7.09M11.92M4.53M4.18M2.58M
Surprise
0.00%
0.00%
0.00%
-100.00%
-100.00%
-69.25%
-100.00%
-97.12%
-81.62%
-67.90%
-73.30%
-52.54%

Earnings Call